Familial hypercholesterolaemia

Children at risk of FH because they have 1 parent with the condition are offered diagnostic tests by the age of 10 years. Source guidance Familial hypercholesterolaemia: identification and management. NICE guideline CG71 (2008, updated 2019), recommendation 1.1.15 Definitions of terms used in this quality statement Familial hypercholesterolaemia (FH) FH relates to heterozygous FH only. Children at risk of FH Children (under 10 years) with 1 affected parent. Diagnostic tests Children at risk of FH because of 1 affected parent receive either of the following diagnostic tests: • A DNA test if the family mutation is known. • LDL-C concentration measurement if the family mutation is not known. When excluding a diagnosis of FH a further LDL-C measurement should be repeated after puberty because LDL-C concentrations change during puberty. [Adapted from NICE's guideline on familial hypercholesterolaemia] Specialist with expertise in FH in children and young people A healthcare professional with expertise in FH in children and young people who has access to the wider skills of a multidisciplinary team. This team should include a dietitian, cardiologist and paediatrician, and a clinical genetic specialist to take a family history and obtain informed consent for a DNA test. All children and young
